The second generation of COX-2 inhibitors: what advantages do the newest offer?

The second generation of COX-2 inhibitors: what advantages do the newest offer?

Item
http://www.wikidata.org/entity/Q35028375
The Efficacy and Clinical Safety of Various Analgesic Combinations for Post-Operative Pain after Third Molar Surgery: A Systematic Review and Meta-AnalysisParecoxib: a shift in pain management?Current approaches to prevent NSAID-induced gastropathy--COX selectivity and beyondComparing etoricoxib and celecoxib for preemptive analgesia for acute postoperative pain in patients undergoing arthroscopic anterior cruciate ligament reconstruction: a randomized controlled trial.Pharmacokinetics and metabolism of orally administered firocoxib, a novel second generation coxib, in horses.Drug bioactivation, covalent binding to target proteins and toxicity relevance.Parecoxib and indomethacin delay early fracture healing: a study in rats.Constitutive cyclooxygenase-2 is involved in central nociceptive processes in humans.Synthesis and anti-inflammatory activity of novel pyridazine and pyridazinone derivatives as non-ulcerogenic agents.Assessment of the safety of selective cyclo-oxygenase-2 inhibitors: where are we in 2003?Negative effect of parecoxib on bone mineral during fracture healing in rats.Effects of parecoxib on plasma protein extravasation and c-fos expression in the rat.Parecoxib sodium reduces the need for opioids after tonsillectomy in children: a double-blind placebo-controlled randomized clinical trial.Pre-emptive parecoxib and post-operative cognitive function in elderly patients.C-Phycocyanin and Phycocyanobilin as Remyelination Therapies for Enhancing Recovery in Multiple Sclerosis and Ischemic Stroke: A Preclinical Perspective.Tulsi oil as a potential penetration enhancer for celecoxib transdermal gel formulations.Effect of antibiotics and NSAIDs on cyclooxygenase-2 in the enamel mineralization.
P2860

The second generation of COX-2 inhibitors: what advantages do the newest offer?

Item
http://www.wikidata.org/entity/Q35028375
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The second generation of COX-2 inhibitors: what advantages do the newest offer?
@ast
The second generation of COX-2 inhibitors: what advantages do the newest offer?
@en
type
label
The second generation of COX-2 inhibitors: what advantages do the newest offer?
@ast
The second generation of COX-2 inhibitors: what advantages do the newest offer?
@en
prefLabel
The second generation of COX-2 inhibitors: what advantages do the newest offer?
@ast
The second generation of COX-2 inhibitors: what advantages do the newest offer?
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
The second generation of COX-2 inhibitors: what advantages do the newest offer?
@en
P2093
P2888
P304
P31
P356
10.2165/00003495-200363010-00003
P433
P478
P577
P6179
P698